Pure Global

Myoglobin Rapid Test - India CDSCO Medical Device Registration

Myoglobin Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000106_7552a1661ce77d9f6eb80fea62d0125f_3e51608cb609999452935a833cc8ad45. This device is marketed under the brand name hCG. The license holder is Medlera Healthcare, and it is classified as Device Class Class B. The approving authority is Gujarat.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Myoglobin Rapid Test
UID: MFG/IVD/2023/000106_7552a1661ce77d9f6eb80fea62d0125f_3e51608cb609999452935a833cc8ad45

Brand Name

hCG

License Holder

Medlera Healthcare

Device Class

Class B

Approving Authority

Gujarat

Product Information

Myoglobin rapid test is an immunochromatographic assay intended for the qualitative detection of elevated levels of Myoglobin in human whole blood, serum or plasma samples to aid in diagnosis of myocardial infraction

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing